SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-18-008219
Filing Date
2018-01-10
Accepted
2018-01-10 16:05:33
Documents
3
Period of Report
2018-01-10
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d523821d8k.htm 8-K 19560
2 EX-99.1 d523821dex991.htm EX-99.1 11207
3 GRAPHIC g523821g25i11.jpg GRAPHIC 8607
  Complete submission text file 0001193125-18-008219.txt   44043
Mailing Address 8000 MARINA BOULEVARD SUITE 300 BRISBANE CA 94005-1884
Business Address 8000 MARINA BOULEVARD SUITE 300 BRISBANE CA 94005-1884 (650) 614-5220
Aimmune Therapeutics, Inc. (Filer) CIK: 0001631650 (see all company filings)

IRS No.: 452748244 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37519 | Film No.: 18521585
SIC: 2834 Pharmaceutical Preparations